Erschienen in:
09.11.2017 | Hepatobiliary Tumors
Importance of Platelet Indices in Hepatocellular Carcinoma Prognosis
verfasst von:
Erdim Sertoglu, MD, Huseyin Kayadibi, MD, Metin Uyanik, MD
Erschienen in:
Annals of Surgical Oncology
|
Sonderheft 3/2017
Einloggen, um Zugang zu erhalten
Excerpt
We read with great interest the article by Shen et al.
1 who aimed to evaluate the prognostic value of platelet-based indices, including platelet count, platelet/lymphocyte ratio (PLR), and aspartate aminotransferase (AST) to platelet ratio index (APRI) in hepatitis B virus (HBV)-induced hepatocellular carcinoma (HCC) after hepatic resection. In their conclusions, Shen et al. stated that elevated platelet-based inflammatory indices, especially APRI, were found to be associated with adverse characteristic features and poor prognosis in HCC, especially for patients with HBV infection or cirrhosis. However, we would like to share our thoughts and contributions to this study. …